Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 41,200 shares, a growth of 34.2% from the March 31st total of 30,700 shares. Based on an average daily volume of 13,300 shares, the days-to-cover ratio is presently 3.1 days.

Algernon Pharmaceuticals Price Performance

OTCMKTS:AGNPF opened at $0.09 on Friday. The company has a 50 day simple moving average of $0.07 and a two-hundred day simple moving average of $0.06. Algernon Pharmaceuticals has a fifty-two week low of $0.04 and a fifty-two week high of $0.20.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.